Stay informed with the latest litigation news. Explore now
Novel Renin Inhibitor - EP2933248B1
EP2933248
- Application Number
- EP13836321A
- Filing Date
- Sep 13, 2013
- Status
- No Opposition Filed Within Time Limit
- Dec 7, 2018
- Grant Date
- Jan 31, 2018
- External Links
- Slate, Register, Google Patents
- Similar Patents facing opposition
Bibliography
The patent EP2933248B1 was granted to Mitsubishi Tanabe Pharma on Jan 31, 2018 following the initial filing on Sep 13, 2013 under the application number EP13836321A . The current legal status of the patent is No Opposition Filed Within Time Limit.
Patent Summary
Patent Family New
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Get instant alerts for new documents